Biomedical significance of endothelial cell specific growth factor, angiopoietin

Experimental and Molecular Medicine

Volumn 34, Issue 1, 2002, Pages 1-11

  Koh, Gou Young ^a   Kim, Injune ^a   Kwak, Hee Jin ^a   Yun, Mi Jeong ^a   Leem, Jae Chan ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Angiopoietin 1; Angiopoietin 2; Tie2

Indexed keywords

AMINO ACID; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOTENSIN; CELL ADHESION MOLECULE; CYTOKINE; GELATINASE A; LEPTIN; MESSENGER RNA; PLASMIN; PROTEIN TYROSINE KINASE; STAT PROTEIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANGIOGENIC FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; MEMBRANE PROTEIN; MEN1 PROTEIN, HUMAN; ONCOPROTEIN; SIGNAL PEPTIDE; TUMOR PROTEIN; VASCULOTROPIN A;

ADHESION; ANGIOGENESIS; BINDING AFFINITY; BLOOD CLOTTING; CELL SURVIVAL; ENDOTHELIUM CELL; GENITAL SYSTEM; HEMATOPOIESIS; HUMAN; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; ALTERNATIVE RNA SPLICING; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SIGNAL TRANSDUCTION; UROGENITAL SYSTEM; VASCULAR ENDOTHELIUM;

ALTERNATIVE SPLICING; ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CELL SURVIVAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HEMATOPOIESIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; UROGENITAL SYSTEM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037204425     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2002.1     Document Type: Review

References (79)

1. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
2. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma
3. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
4. Mechanisms of angiogenesis and arteriogenesis
5. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
6. Angiogenesis in cancer and other diseases
7. Co-administration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization
8. Endothelial cells in physiology and in the pathophysiology of vascular disorders
9. Leptin induces angiopoietin-2 expression in adipose tissues
10. Isolation of angiopoietin-1, a ligand for the TIE2 receptor by secretion-trap expression cloning
11. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
12. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells
13. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors
14. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development
15. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
16. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases
17. The biology of vascular enclothelial growth factor
18. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation
19. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions
20. Role of angiopoietins in reproductive tract angiogenesis
21. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
22. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: A receptor ligand model for vascular remodelling
23. Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations
24. Expression and function of angiopoietin-1 in breast cancer
25. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
26. Identification of a family of alternatively spliced mRNA species of anglopoietin-1
27. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
28. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells
29. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R
30. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration
31. Hepatic expression, synthesis and secretion of novel angiopoietin-related protein prevents endothelial cell apoptosis
32. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion
33. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway
34. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
35. Characterization and expression of a novel alternatively spliced human angiopoietin-2
36. Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells
37. Angiopoietin-1 inhibits VEGF-induced tissue factor mRNA and proteins through PI 3′-kinase/Akt activation in endothelial cells
38. VEGF stimulates expression of ICAM-1, VCAM-1 and E-Selectin through nuclear factor-κB activation in endothelial cells
39. Molecular cloning, expression and characterization of angiopoietin-related protein
40. The angiopoietin-Tie2 System in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis
41. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-Selectin expression
42. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3′-kinase and Akt
43. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant Tie-2 causing venous malformations signals a distinct STAT activation response
44. Angiopoietin-1 is an apoptosis survival factor for endothelial cells
45. Angiopoietin-1 inhibits radiation-, and mannitol-induced apoptosis in endothelial cells
46. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
47. Angiopioetin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
48. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
49. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia
50. Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak
51. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
52. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
53. Endothelial receptor tyrosine kinases involved in angiogenesis
54. Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells
55. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells
56. The genetic program of hematopoietic stem cells
57. Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium
58. Mechanisms of angiogenesis
59. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
60. Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice
61. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 auguments revascularization in the rabbit ischemic hindlimb
62. Endothelial apoptosis: Could it have a role in the pathogenesis and treatment of disease?
63. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
64. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
65. Increased vascularization in mice overexpressing angiopoietin-1
66. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
67. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis
68. A role for hematopoietic stem cells in promoting angiogenesis
69. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb-model
70. Angiopoietin-1 protects the adult vasculature against plasma leakage
71. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
72. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
73. Receptor protein-tyrosine kinases and their signal transduction pathways
74. VEGFs, receptors and angiogenesis
75. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
76. Vascular-specific growth factors and blood vessel formation
77. Expression of angiostatic factors in colorectal cancer
78. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells
79. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis